secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2022-08-15T23:59:59+00:00
Accession:  0001510964-22-000065
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences Q2 2022 revenue falls 19% to $4.1M; gross margin drops to 30.7%
---------------------------------------------------------------------------

- Revenue $4.1M down from $5.1M YoY; units sold decreased 5%.
- Gross margin 30.7% vs 44.7% in Q2 2021, hurt by product mix and higher discounts.
- Operating loss narrowed to $2.3M from $3.5M; adj. EBITDA loss $1.8M (vs $2.4M).
- Cash balance $1.1M at quarter end; OPEX reduced 38.2% YoY.
- Regained top hemp extract brand in natural retail per SPINS; strategic review ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000065/0001510964-22-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000065/cvsi-20220815.htm
  HTML page:      https://secwatch.observer/filing/0001510964-22-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer